Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

772.87
-7.8000-1.00%
Post-market: 771.00-1.8700-0.24%19:59 EDT
Volume:2.58M
Turnover:1.98B
Market Cap:732.48B
PE:62.89
High:781.15
Open:780.68
Low:762.03
Close:780.67
Loading ...

Eli Lilly, Apollo Clinic Partner to Drive Obesity, Type 2 Diabetes Awareness in India - Statement

THOMSON REUTERS
·
29 May

‘Start a Position’ in Eli Lilly Stock (LLY), Says Jim Cramer

TIPRANKS
·
29 May

Heart Disease Could Be a Goner When These New Drugs Arrive -- Barrons.com

Dow Jones
·
29 May

Eli Lilly & Co. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Eli Lilly's SVP, Finance & CAO Donald A. Zakrowski Reports Disposal of Common Shares

Reuters
·
28 May

BRIEF-Lilly To Expand Its Pain Pipeline With Acquisition Of Siteone Therapeutics

Reuters
·
28 May

Mixed options sentiment in Eli Lilly with shares up 1.93%

TIPRANKS
·
28 May

Eli Lilly’s Strategic Acquisition of SiteOne Therapeutics Bolsters Pain Management Portfolio and Supports Buy Rating

TIPRANKS
·
28 May

BMO says Eli Lilly ‘well-priced deal’ to expand presence in pain a positive

TIPRANKS
·
27 May

Eli Lilly to Buy SiteOne Therapeutics

MT Newswires Live
·
27 May

Eli Lilly to acquire privately held SiteOne

Reuters
·
27 May

Lilly to Expand Its Pain Pipeline With Acquisition of SiteOne Therapeutics

THOMSON REUTERS
·
27 May

Eli Lilly and Co - SiteOne Shareholders to Receive up to $1 Bln in Cash

THOMSON REUTERS
·
27 May

What's the Price Outlook for Weight-Loss Drugs? -- Journal Report

Dow Jones
·
27 May

Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly

Motley Fool
·
27 May

Eli Lilly (LLY) Considers New $5.9 Billion Plant in Houston, Texas

TIPRANKS
·
27 May

Should Everyone Be Taking Ozempic? Doctors Say More People Could Benefit. -- WSJ

Dow Jones
·
26 May

Australia Approves Eli Lilly’s (LLY) Kisunla Alzheimer’s Medication

TIPRANKS
·
23 May

Lilly's Secret Growth Engine Unleashed

TradingKey
·
23 May

Guggenheim Adjusts Price Target on Eli Lilly to $936 From $928, Maintains Buy Rating

MT Newswires Live
·
23 May